Paraneoplastic glomerulopathies associated with hematologic malignancies

1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Paraneoplastic glomerulopathy (PG) includes a group of glomerular lesions that are not directly related to tumor burden, invasion, or metastasis, but induced by products from tumor cells such as hormones, growth factors, cytokines, and tumor antigens. PG was first described by Galloway in 1922, in which nephrotic syndrome (NS) secondary to Hodgkin's lymphoma was reported. They can present before, at the time of diagnosis, during remission, or at relapse of the hematological malignancies. We present three cases of paraneoplastic NS associated with hematological malignancies. Early diagnosis and treatment can alter prognosis of these patients. Paraneoplastic syndromes would remit only with proper treatment of the neoplasia.

Cite

CITATION STYLE

APA

Dhanapriya, J., Dineshkumar, T., Sakthirajan, R., Surendar, D., Gopalakrishnan, N., & Balasubramaniyan, T. (2018). Paraneoplastic glomerulopathies associated with hematologic malignancies. Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 29(2), 452–455. https://doi.org/10.4103/1319-2442.229260

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free